WAVEMAN · COMPANY

CLX · Clorox Co /De/

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

CLX

Name: CLOROX CO /DE/ (CLX) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CLOROX CO /DE/

PHARMA & BIOTECH · SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS · CIK 0000021076

CONGRESS · 2☆ WATCH

INSIDER NET · 180D

$429.1K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

542

13F, latest reported quarter

REVENUE GROWTH

+0.2%

XBRL, annual

NET MARGIN

11.4%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$429.1K over 180 days

more than 84% of Pharma & Biotech

CONGRESS

2 members bought in the last year

more than 65% of Pharma & Biotech

FUNDS

542 funds added or opened last quarter

more than 97% of Pharma & Biotech

REVENUE

+0.2% year over year

below 54% of Pharma & Biotech

MARGIN

11.4% net margin

more than 82% of Pharma & Biotech

BUYBACKS

$256.0M repurchased, FY to 2026-03-31

more than 80% of Pharma & Biotech

SHORT

11.2% of shares outstanding short · 6.0 days to cover · settled 2026-07-31

more than 81% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

542 funds added or opened positions in the latest 13F quarter, of 1,049 holders.

2 members of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -17.7%

-17.7%12M

INSIDER BUYINSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $429.1K bought by insiders over 180 days, 542 funds added last quarter, 2 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CLOROX CO /DE/ insiders bought a net $429.1K of stock across 16 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Breber Pierre R

Director

BUY

2026-05-05

5,000.0

$429.1K

Breber Pierre R

Director

BUY

2025-11-21

4,000.0

$416.5K

Reynolds Eric H

EVP - Chief Operating Officer

SELL

2025-09-04

15,041.0

$1.9M

Breber Pierre R

Director

BUY

2025-05-07

4,000.0

$546.3K

Marriner Kirsten

EVP - Chief People Officer

SELL

2025-03-11

733.0

$110.0K

16 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 11 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,044,423.0 sh

$958.6M

STATE STREET CORP

8,432,523.0 sh

$804.8M

VANGUARD CAPITAL MANAGEMENT LLC

7,896,390.0 sh

$753.6M

Invesco Ltd.

6,010,072.0 sh

$573.6M

VANGUARD PORTFOLIO MANAGEMENT LLC

5,799,952.0 sh

$553.5M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Nuance Concentrated Value Fund

$4.3M POSITION · AS OF 2026-04-30

10.1%

Nuance Mid Cap Value Fund

$13.9M POSITION · AS OF 2026-04-30

4.8%

VictoryShares Dividend Accelerator ETF

$5.9M POSITION · AS OF 2026-03-31

2.7%

VanEck Morningstar Wide Moat ETF

$303.7M POSITION · AS OF 2026-03-31

2.6%

VanEck Morningstar Wide Moat Fund

$879.2K POSITION · AS OF 2026-03-31

2.6%

JNL/Morningstar Wide Moat Index Fund

$18.5M POSITION · AS OF 2026-03-31

2.6%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Corporate PAC

FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors

Clorox Employees' Political Action Committee

CYCLE 2026 · $1K SPENT

FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-06	2024-06	2023-06	2022-06
REVENUE	$7.1B	$7.1B	$7.4B	$7.1B
GROSS PROFIT	$3.2B	$3.0B	$2.9B	$2.5B
NET INCOME	$810.0M	$280.0M	$149.0M	$462.0M
EPS (DILUTED)	6.52	2.25	1.20	3.73
OPERATING CASH FLOW	$981.0M	$695.0M	$1.2B	$786.0M
CASH	$167.0M	$202.0M	$367.0M	$183.0M
LONG-TERM DEBT	$2.5B	$2.5B	$2.5B	$2.5B
BUYBACKS	$332.0M	$0	$0	$25.0M
DIVIDENDS PAID	$602.0M	$595.0M	$583.0M	$571.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE